MENU
ACOG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alpha Cognition (ACOG) Ownership - Who owns Alpha Cognition?

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease, for which there are limited or no treatment options... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
135.89M
P/E Ratio
N/A
Total Cash
35.4M
Projected Growth
N/A
Total Debt
2.21M
Revenue
7.43M
Risk (Beta)
2.77
Dividend Yield
N/A
Total Cash/Share
1.63
Total Debt/Equity
N/A
Revenue/Share
0.50 USD as % of share price

Fundamentals

ACOG
Capitalization
136M
P/E Ratio
N/A
Risk (Beta)
2.77
Dividend Yield
N/A
Total Cash
35.4M
Total Cash/Share
1.63
Total Debt
2.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.50%
Revenue
7.43M
ROE
N/A
Book Value
33.9M
P/B Ratio
4.01
Cash Flow
N/A
Earnings
-1.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
102M
Current Ratio
6.69
Current Revenue Per Employee
49839.61
Dividends Per Share - Security
N/A
EBITDA
-20.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
77.89
Revenue To Assets
-75.87
Shares Held By Institutions
36.8M
Shares Outstanding - Current
21.7M
Total Liabilities
12.4M
Total Volume MTD
N/A
Value
1
Gain YTD
6.112
View a ticker or compare two or three
ACOG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details